MetaCap

First Tracks Biotherapeutics Statistics

NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.64-2.82 (-6.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

First Tracks Biotherapeutics by the numbers

First Tracks Biotherapeutics has a market capitalization of $1.75 billion based on 42.02M shares outstanding. With trailing EPS of $-4.71, First Tracks Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.1% above its 50-day average and 30.0% above its 200-day average.

Average daily trading volume is 826.70K shares, or about $34.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TRAX valuation vs. peer median

TRAX compared with the median of 8 peer companies
MetricTRAXPeer medianDifference
Market cap$1.75B$1.74B+1%
Avg. volume826.70K1.05M-22%

Peer median across 8 companies: STOK, ETON, SDGR, KRSA, ZYME, MRVI, RARE, BRVE.

Valuation

Price and trading

Previous close
44.46
Open
43.99
Day range
41.51 – 44.51
52-week range
14.72 – 54.78
Beta
—
Volume
504.36K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.75B
Forward Pe
-12.03
Eps
-4.71
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
54.78
Week52 Low
14.72
Avg Volume
826.70K
Shares Outstanding
42.02M
Ma50
40.39
Ma200
32.04
Earnings Date
Nov 3, 2026
Pct From52w High
-23.99%
Pct From52w Low
182.88%

Related